Abstract
This papers deals with the preanalytical and analytical phase of cell-free DNA analysis, highlighting some criticism on sample collection and extraction. We describe a method to accurately quantify total cfDNA in plasma and our particular approach to the measurement of tumor deriving cfDNA.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tsang JC, Lo YM (2007) Circulating nucleic acids in plasma/serum. Pathology 39:197–207
Fleischhancker M, Schmidt B (2006) Circulating nucleic acids (CNAs) and cancer—a survey. Biochim Biophys Acta 1775:181–232
Mandel P, Metais P (1948) Les acides nucléiques du plasma sanguine chez l’homme. C R Acad Sci Paris 142:241–243
Leon SA, Shapiro B, Sklaroff DM et al (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646–650
Georgiou CD, Patsoukis N, Papapostolou I (2005) Assay for the quantification of small-sized fragmented genomic DNA. Anal Biochem 339:223–230
Holdenrieder S, Stieber P (2004) Apoptotic markers in cancer. Clin Biochem 37:605–617
Nagata S (2005) DNA degradation in development and programmed cell death. Cell Death Differ 10:108–116
Jahr S, Hentze H, Englisch S et al (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61:1659–1665
Gormally E, Caboux E, Vineis P et al (2007) Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635:105–117
Gahan PB, Swaminathan R (2008) Circulating nucleic acids in plasma and serum. Recent developments. Ann N Y Acad Sci 1137:1–6
Gahan PB, Anker P, Stroun M (2008) Metabolic DNA as the origin of spontaneously released DNA? Ann N Y Acad Sci 1137:7–17
Stroun M, Anker P, Lyautey J et al (1987) Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23:707–712
Jung M, Klotzek S, Lewandowski M et al (2003) Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 49:1028–1029
Lam NYL, Rainer TH, Chiu RWK et al (2004) EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. Clin Chem 50:256–257
Chiang P, Beer DG, Wei W et al (1999) Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. Clin Cancer Res 5:1381–1386
Chiu RWK, Poon LLM, Lau TK et al (2001) Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 47:1607–1613
Swinkels DW, Wiegerinck E, Steegers EA et al (2003) Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin Chem 49:525–526
Lui YY, Chik KW, Lo YM (2002) Does centrifugation cause the ex vivo release of DNA from blood cells? Clin Chem 48:2074–2076
Kopreski MS, Benko FA, Kwee C et al (1997) Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76:1293–1299
Lee T, LeShane ES, Messerlian GM et al (2002) Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 187:1217–1221
Kopreski MS, Benko FA, Kwak LW et al (1999) Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5:1961–1965
Sozzi G, Roz L, Conte D et al (2005) Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 97:1848–1850
Jung K, Fleischhacker M, Rabien A (2010) Cell-free DNA in the blood as a solid tumor biomarker—a critical appraisal of the literature. Clin Chim Acta 411:1611–1624
van der Vaart M, Pretorius PJ (2008) Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci 1137:18–26
Pinzani P, Salvianti F, Cascella R et al (2010) Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. Clin Chim Acta 411:1319–1324
Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954
Vdovichenko KK, Markova SI, Belokhvostov AS (2004) Mutant form of BRAF gene in blood plasma of cancer patients. Ann N Y Acad Sci 1022:228–231
Cradic KW, Milosevic D, Rosenberg AM et al (2009) Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status. J Clin Endocrinol Metab 94:5001–5009
Chuang TC, Chuang AY, Poeta L et al (2010) Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas. Head Neck 32:229–234
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Pinzani, P., Salvianti, F., Orlando, C., Pazzagli, M. (2014). Circulating Cell-Free DNA in Cancer. In: Biassoni, R., Raso, A. (eds) Quantitative Real-Time PCR. Methods in Molecular Biology, vol 1160. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0733-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0733-5_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0732-8
Online ISBN: 978-1-4939-0733-5
eBook Packages: Springer Protocols